ArticleBiotechnology for biofuels and bioproducts2026
From beet molasses to malic acid: holistic development of fermentation and downstream process.
Article in Biotechnology for biofuels and bioproducts, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adaptive Laboratory Evolution of the Non-Conventional YeastMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe growing demand for sustainable alternatives to fossil-based chemicals has increased interest in platform chemicals derived from renewable biomass sources, such as malic acid. This C4 dicarboxylic acid is valued for its diverse application potential in food, pharmaceuticals, and bioplastics. Sustainable platform chemicals remain commercially uncompetitive primarily due to high production costs driven by high substrate costs. Microbial production using more cost-effective feedstocks like sugar beet molasses shows promise. However, it faces challenges from high osmolality, growth inhibitors, and predetermined substrate composition during fermentation, as well as elevated pigmentation that complicates downstream processing. Moreover, the separation techniques typically used for highly polar carboxylic acids face considerable yield limitations due to the high solubility of malic acid and its salts.
resultsThis study developed an all-encompassing production process for malic acid from untreated sugar beet molasses. Fermentative malic acid production with Ustilago trichophora was investigated in batch, fed-batch, and pulsed batch in shake flask scale, followed by a scale-up into 150 L pilot scale. A total of 15.7 kg malic acid was produced in a repeated pulsed batch with membrane-based cell retention with a titer of 108 g/L, a yield of 0.50 g/g, and a space-time yield of 0.66 g/L/h (max. 1.1 g/L/h). In addition, the byproduct succinic acid was detected in concentrations of up to 22.9 g/L. In the subsequent downstream processing, activated carbons were used for two-stage product capture, solvent change, and decolorization, followed by crystallization of the products malic acid and succinic acid. Based on experimental results, an Aspen Plus model was developed to estimate the overall process yields of 0.43 g malic acid (98% purity) and 0.10 g succinic acid per gram sucrose equivalent. A techno-economic analysis suggests production costs within the range of current market prices.
conclusionAgricultural residue streams are often proposed as cost-effective alternatives for fermentative platform chemical production, although the challenges addressed hamper the direct transfer of process strategies from established organic acid production. By presenting a holistic approach explicitly tailored to malic acid production from untreated molasses, this work demonstrates the techno-economic feasibility of the developed process at a meaningful scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.